
UK supermarket chain Asda has started selling privately prescribed cancer drugs on a not-for-profit basis. The vast majority of drugs …
The economic woes of Greece are currently the most worrying problem within the European Union’s single currency region the Eurozone, …
A Munich court has ruled GlaxoSmithKline’s combination patent for its asthma and COPD treatment Seretide is not valid. The Federal …

UK online doctors network Doctors.net.uk has taken a stake in its Swedish counterpart MedUniverse as part of international expansion plans. …
Abbott has acquired Indian firm Piramal’s Healthcare Solutions business in a deal that is set to make it the number …
Dermatology specialist Galderma UK has appointed advertising agency Woolley Pau to work on a number of product launches. The agency …
The NHS can expect real term increases in health spending and a significant reduction in its administration burden, according to …
Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …

Boehringer Ingelheim will shortly unveil a ‘digital diabetes hub’ that combines educational videos, research tools, educational games and information on …
Sanofi-Aventis is to be investigated by the French Competition Authority for anti-competitive practices, following allegations it prevented the launch of …
Roche and Biogen Idec will discontinue clinical trials for rheumatoid arthritis drug ocrelizumab. Development of the RA treatment was halted …
UK biotech Antisoma is looking to put previous late-stage trial failures behind it by focusing on two new cancer drugs. …
French-based communications group Publicis has acquired independent UK healthcare communications agency Resolute Communications. London-based Resolute will be merged with Publicis …
Jeff Solomon has joined Bioscience NEDs as a non-executive advisor.He is currently chairman of the Council for European Bioregions and a non-executive director …
A new survey shows pharma employees are now more loyal despite turbulent economic changes within the industry. Conducted by recruitment …
ReNeuron’s chief scientific officer discusses his career to date. How did you find your way into your current role?
Indian authorities have revoked a patent granted in 2007 for Roche’s brand Valcyte, saying it had been wrongly granted.The decision was welcomed …
Pfizer is to reduce manufacturing staffing by around 6,000 – around 18% of its total production workforce – and close …
This builds further upon Chiltern’s well established operation in India. Chiltern is also in the process of forming a company …
UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …